Kailera Therapeutics, Inc
NYSE · KLRA
Fundamentals
Market cap
$2.19B
Price / Earnings ratio
-14.8x
Price / Sales ratio
N/A
Price / Book ratio
-5.1x
Return on assets
N/A
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A


